Energy expenditure and fat metabolism in vivo have not been accurately assessed in patients with Prader-Willi syndrome (PWS). This study aims to determine if daily energy expenditure (EE) and in vivo fat metabolism differ between PWS subjects and normal obese controls by using a state- of-the-art wholeroom indirect calorimeter to measure 24 hr EE, and isotope dilution methods. In addition, activity will be measured in the normal environment using an accelerometer. Infusions of [2H5] glycerol and [1-13C] palmitate will be given to determine rates of lipolysis and free fatty acid esterification (triglyceride synthesis). Body composition will be determined using a variety of techniques (dual energy x-ray absorptiometry, magnetic resonance imaging, and bioelectrical impedence), and the relationship between fat and fat-free mass and energy expenditure will be computed and compared between patients and controls. Adult PWS patients will complete a 14 week treadmill training program, as described in the project on food motivation and behavior. These subjects will have measurements of 24 EE, in vivo fat metabolism, body composition, and activity, pre-and post-training. Fat biopsies will be assessed for fat cell number and size as well as lipoprotein lipase activity. The relationship between these measures in fat and measures of energy expenditure, activity and body composition will be determined. Obese adult controls will have one fat biopsy taken for comparison to patients. Child/adolescent PWS patients and controls will have follow up measurements of 24 hr EE, body composition and activity 10-16 weeks after their initial assessment to determine if these variables change over time and if so, whether these changes can be predicted from any of the initial measures.

Project Start
1998-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Butler, Merlin G (2017) Benefits and limitations of prenatal screening for Prader-Willi syndrome. Prenat Diagn 37:81-94
Hellings, Jessica A; Boehm, Danna; Yeh, Hung Wen et al. (2011) Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. J Ment Health Res Intellect Disabil 4:40-52
Bittel, D C; Yu, S; Newkirk, H et al. (2009) Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res 124:113-20
Butler, Merlin G; Fischer, William; Kibiryeva, Nataliya et al. (2008) Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A 146:854-60
Bittel, Douglas C; Kibiryeva, Nataliya; Butler, Merlin G (2007) Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Genet Test 11:467-75
Butler, Merlin G; Theodoro, Mariana F; Bittel, Douglas C et al. (2007) Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A 143:449-59
Butler, Merlin G; Bittel, Douglas C (2007) Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Genet A 143:415-21
Butler, Merlin G; Theodoro, Mariana; Skouse, Jennifer D (2007) Thyroid function studies in Prader-Willi syndrome. Am J Med Genet A 143:488-92
Butler, Merlin G; Theodoro, Mariana F; Bittel, Douglas C et al. (2007) X-chromosome inactivation patterns in females with Prader-Willi syndrome. Am J Med Genet A 143:469-75
Kennedy, L; Bittel, D C; Kibiryeva, N et al. (2006) Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) 30:382-7

Showing the most recent 10 out of 38 publications